TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Biotech Fluidics AB
Closing information (x1000 DKK)
Closing information | 2022/12 | 2021/12 | 2020/12 |
Turnover |
67,629
|
51,172
|
41,179 |
Financial expenses |
1
|
3
|
8 |
Earnings before taxes |
9,781
|
7,451
|
3,048 |
EBITDA |
9,103
|
4,995
|
2,556 |
Total assets |
30,673
|
21,736
|
14,617 |
Current assets |
27,483
|
18,239
|
11,444 |
Current liabilities |
10,507
|
6,533
|
4,351 |
Equity capital |
19,119
|
14,224
|
9,577 |
- share capital |
67
|
73
|
74 |
Employees (average) |
13
|
12
![]() |
12 |
Financial ratios
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Solvency |
62.3%
|
65.4%
|
65.5% |
Turnover per employee |
5,202
|
4,264
|
3,432 |
Profit as a percentage of turnover |
14.5%
|
14.6%
|
7.4% |
Return on assets (ROA) |
31.9%
|
34.3%
|
20.9% |
Current ratio |
261.6%
|
279.2%
|
263.0% |
Return on equity (ROE) |
51.2%
|
52.4%
|
31.8% |
Change turnover |
20,602
|
10,772
|
3,042 |
Change turnover % |
44%
|
27%
|
8% |
Chg. No. of employees |
1
|
0
|
2 |
Chg. No. of employees % |
8%
|
0%
|
20% |
Total value of public sale
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.